Joseph S. Anderson

2.3k total citations
47 papers, 1.8k citations indexed

About

Joseph S. Anderson is a scholar working on Molecular Biology, Genetics and Virology. According to data from OpenAlex, Joseph S. Anderson has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 22 papers in Genetics and 15 papers in Virology. Recurrent topics in Joseph S. Anderson's work include Virus-based gene therapy research (19 papers), RNA Interference and Gene Delivery (19 papers) and HIV Research and Treatment (15 papers). Joseph S. Anderson is often cited by papers focused on Virus-based gene therapy research (19 papers), RNA Interference and Gene Delivery (19 papers) and HIV Research and Treatment (15 papers). Joseph S. Anderson collaborates with scholars based in United States, United Kingdom and France. Joseph S. Anderson's co-authors include Ramesh Akkina, Akhil C. Banerjea, Jan A. Nolta, Ming-Jie Li, John J. Rossi, Mark C. Enright, Gerhard Bauer, John A. Zaia, Jiing-Kuan Yee and Shirley Xin Li and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Human Molecular Genetics.

In The Last Decade

Joseph S. Anderson

45 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph S. Anderson United States 24 1.1k 530 501 355 274 47 1.8k
F. Hill United Kingdom 25 1.4k 1.4× 280 0.5× 517 1.0× 421 1.2× 440 1.6× 59 2.5k
Richard Peluso United States 27 1.2k 1.1× 793 1.5× 349 0.7× 478 1.3× 192 0.7× 38 2.7k
Yiming Xie United States 24 943 0.9× 510 1.0× 369 0.7× 300 0.8× 400 1.5× 49 1.7k
Kristine E. Yoder United States 18 899 0.8× 179 0.3× 379 0.8× 299 0.8× 80 0.3× 40 1.4k
Iyoko Katoh Japan 21 1.2k 1.1× 243 0.5× 493 1.0× 400 1.1× 408 1.5× 40 2.2k
Jennifer Richardson France 25 691 0.7× 315 0.6× 267 0.5× 494 1.4× 366 1.3× 77 2.1k
Kathryn S. Jones United States 22 1.1k 1.0× 255 0.5× 704 1.4× 645 1.8× 960 3.5× 48 2.4k
Andreas S. Puschnik United States 18 1.2k 1.1× 565 1.1× 158 0.3× 573 1.6× 372 1.4× 27 2.1k
Anthony P. Schmitt United States 23 830 0.8× 328 0.6× 192 0.4× 422 1.2× 257 0.9× 36 2.0k
J. Bradford Bowzard United States 18 584 0.6× 188 0.4× 278 0.6× 330 0.9× 596 2.2× 22 1.5k

Countries citing papers authored by Joseph S. Anderson

Since Specialization
Citations

This map shows the geographic impact of Joseph S. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph S. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph S. Anderson more than expected).

Fields of papers citing papers by Joseph S. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph S. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph S. Anderson. The network helps show where Joseph S. Anderson may publish in the future.

Co-authorship network of co-authors of Joseph S. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph S. Anderson. A scholar is included among the top collaborators of Joseph S. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph S. Anderson. Joseph S. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, Joseph S., et al.. (2024). Hematopoietic stem cell gene therapy for the treatment of SYNGAP1‐related non‐specific intellectual disability. The Journal of Gene Medicine. 26(7). e3717–e3717.
2.
Wagner, Joseph, Joseph S. Anderson, Peter Deng, et al.. (2019). Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion. Stem Cells and Development. 28(6). 398–409. 43 indexed citations
3.
Cochrane, R. A., Jordan T Gebhardt, Steven S Dritz, et al.. (2019). Effects of Medium Chain Fatty Acid Application in Swine Feed on Porcine Epidemic Diarrhea Virus. Kansas Agricultural Experiment Station Research Reports. 5(8).
4.
Lamani, Manjunath, Michael S. Malamas, Vidyanand G. Shukla, et al.. (2019). Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology. Bioorganic & Medicinal Chemistry. 27(23). 115096–115096. 11 indexed citations
5.
Roberts, Jane, Joseph S. Anderson, & Heiko Pohl. (2018). Safety and Efficacy of Dedicated Cold versus Standard Snares. The American Journal of Gastroenterology. 113(Supplement). S281–S282. 1 indexed citations
6.
Yang, Yimin, Siruo Zhang, Jan A. Nolta, et al.. (2014). Safety and Efficacy of a tCD25 Preselective Combination Anti-HIV Lentiviral Vector in Human Hematopoietic Stem and Progenitor Cells. Stem Cells. 33(3). 870–879. 10 indexed citations
7.
Anderson, Joseph S.. (2013). Using TRIM5α as an HIV therapeutic: the alpha gene?. Expert Opinion on Biological Therapy. 13(7). 1029–1038. 3 indexed citations
8.
Burrowes, Ben, David R. Harper, Joseph S. Anderson, Malcolm McConville, & Mark C. Enright. (2011). Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Review of Anti-infective Therapy. 9(9). 775–785. 153 indexed citations
9.
Kambal, Amal, Whitney Cary, William Gruenloh, et al.. (2010). Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell–derived Induced Pluripotent Stem Cells. Molecular Therapy. 19(3). 584–593. 56 indexed citations
10.
Anderson, Joseph S., et al.. (2009). Preintegration HIV-1 Inhibition by a Combination Lentiviral Vector Containing a Chimeric TRIM5α Protein, a CCR5 shRNA, and a TAR Decoy. Molecular Therapy. 17(12). 2103–2114. 48 indexed citations
11.
Albritton, M. David, Sharon L. Oswald, & Joseph S. Anderson. (2008). Leadership quality and follower affect: A study of U.S. presidential candidates. Journal of Leadership Studies. 1(4). 6–22. 12 indexed citations
12.
Anderson, Joseph S. & Ramesh Akkina. (2007). Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection. Gene Therapy. 14(17). 1287–1297. 54 indexed citations
13.
Anderson, Joseph S., Sriram Bandi, Dan S. Kaufman, & Ramesh Akkina. (2006). 1046. Derivation of Functionally Normal Macrophages from Human Embryonic Stem (hES) Cells for HIV-1 Gene Therapy. Molecular Therapy. 13. S401–S401. 2 indexed citations
14.
Anderson, Joseph S., Sriram Bandi, Dan S. Kaufman, & Ramesh Akkina. (2006). Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Retrovirology. 3(1). 24–24. 47 indexed citations
16.
Anderson, Joseph S. & Ramesh Akkina. (2005). HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Research and Therapy. 2(1). 1–1. 75 indexed citations
17.
Anderson, Joseph S. & Ramesh Akkina. (2005). CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection. Retrovirology. 2(1). 53–53. 56 indexed citations
18.
Anderson, Joseph S., Akhil C. Banerjea, Vicente Planelles, & Ramesh Akkina. (2003). Potent Suppression of HIV Type 1 Infection By a Short Hairpin Anti-CXCR4 siRNA. AIDS Research and Human Retroviruses. 19(8). 699–706. 66 indexed citations
19.
Anderson, Joseph S., et al.. (1998). Managing Tribal Assets: Developing Long-Term Strategic Plans. American Indian Culture and Research Journal. 22(3). 139–156. 1 indexed citations
20.
Langlands, Kenneth, et al.. (1992). Polymerase chain reaction analysis of tumour contamination in peripheral blood stem cell harvests. Stem Cells. 10(S1). 95–97. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026